AgingResearch.News
Pathology, Research and Practice

Circulating fibroblast growth factor 21 predicts adverse outcomes in patients with pre-heart failure and HFpEF

By Huiying Li, Yu Bao, Hunan Xiao, Show 6 more authorsHongbin Liu
Study in peopleBiomarkers
Paper

The paper

Huiying Li, Yu Bao, Hunan Xiao, Show 6 more authorsHongbin Liu

Chinese PLA General Hospital

Pathology, Research and Practice, 8 Sep 2026

doi.org/10.1016/j.prp.2026.156687PubMed 42727188

Related